Nimacimab
CAS No. 2098636-09-8
Nimacimab( —— )
Catalog No. M36817 CAS No. 2098636-09-8
Nimacimab is a recombinant humanized monoclonal antibody. It can improve diabetes and non-alcoholic steatohepatitis.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 362 | Get Quote |
|
| 5MG | 654 | Get Quote |
|
| 10MG | 1036 | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameNimacimab
-
NoteResearch use only, not for human use.
-
Brief DescriptionNimacimab is a recombinant humanized monoclonal antibody. It can improve diabetes and non-alcoholic steatohepatitis.
-
DescriptionNimacimab is a recombinant humanized monoclonal antibody. It can improve diabetes and non-alcoholic steatohepatitis.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2098636-09-8
-
Formula Weight
-
Molecular Formula——
-
Purity>98% (HPLC)
-
Solubility——
-
SMILES——
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
Halazone
Stable, but may be light sensitive. Incompatible with strong oxidizing agents.
-
Sibrotuzumab
Sibrotuzumab (BIBH 1) is a humanized IgG1 monoclonal antibody targeting Fibroblast Activating Protein (FAP) and is used in the study of colorectal cancer and non-small cell lung cancer.
-
2,4,5-Trichlorobenze...
2,4,5-Trichlorobenzenesulfonyl chloride (TCBSC) is a versatile building block in the synthesis of various organic compounds, such as amines, alcohols, and carboxylic acids.
Cart
sales@molnova.com